In the last 20 years great strides have been made in researching the causes of CHD, and in improving treatment and care for those affected by it. More and more Heartkids are now surviving into adulthood to lead active and productive lives, even if that means a little more care and support is needed to help them along the way. It’s no longer simply about babies and toddlers, now it’s about a growing cross-section of the teenage and adult Australian communities.
Beating CHD is a continuing challenge, but it won’t happen unless there is ongoing high-quality analysis and advice based on an empathic understanding of the need of patients, identifying what works and what is needed to ensure that our ability to treat and care for our fellow Australians with CHD and their families.
This is why HeartKids Australia joined with the Cardiac Society of Australia and New Zealand to commission an independent expert to look at the CHD environment, current and emerging patient and family needs, the available treatment and support services for CHD, and what gaps need to be addressed to make all these as effective as practically possible.The result is the “White Paper” on Childhood Heart Disease in Australia – Current Practices andFuture Needs, prepared by LaTrobe University academic Professor Sandra Leggat.
Professor Leggat consulted objectively and extensively with patients, families, care workers, clinicians and researchers. She looked closely at what is needed to both make CHD manageable for patients, families, care providers and the wider community, and what can be done to keep Australia’s CHD effort as truly world-leading as it is.
Professor Leggat’s “White Paper” makes a number of recommendations targeted at clinicians, the HeartKids community and Commonwealth, State and Territory governments. At a time when hospital-centred health reform is again in the spotlight, she particularly makes some very sensible – and not necessarily greatly expensive – recommendations about better planning, distributing and coordinating CHD services and resources, as well as performance standards that could fit under the sort of monitoring regime just agreed to by the Council of Australian Governments.
Just like a government White Paper, this is a discussion document with suggestions for consideration and adoption. It is not intended as a list of lobbying demands. Above all, HeartKids Australia and the Cardiac Society both want this “White Paper” to be a catalyst of robust discussion and debate in the CHD family and clinical community about not just about what’s best for them, but might just help ensure that the pain and heartbreak of CHD is avoided or mitigated for thousands of future Australian children and their families.